France Coronary Stents Market Report 2022 to 2030

France Coronary Stents Market Analysis

$ 3999

France's Coronary Stents Market is expected to witness growth from $311 Mn in 2022 to $417 Mn in 2030 with a CAGR of 3.75% for the forecasted year 2022-30. In France, stent installation is one of many minimally invasive procedures that are becoming more popular. The use of stents is becoming more popular because patients frequently prefer them to more invasive procedures like bypass surgery. The market is segmented by type, mode of delivery, materials, and end user. Some key players in this market include Stentys, Delacroix-Chevalier, Marquat, B. Braun, Abbott Laboratories, Biotronik, Medtronic, GE Healthcare, Boston Scientific, and Philips Healthcare.

ID: IN10FRMD006 CATEGORY: Medical Devices GEOGRAPHY: France AUTHOR: Jigyasu Bhandari

Buy Now

France Coronary Stents Healthcare Market Executive Analysis

France's Coronary Stents Market is expected to witness growth from $311 Mn in 2022 to $417 Mn in 2030 with a CAGR of 3.75% for the forecasted year 2022-30. Health expenditures in France account for 12.3% of GDP, or $5,370 per person. The population of France is projected to grow by 0.36% in 2023. In Germany, men may expect to live 79.53 years on average, compared to 85.79 for women. France spent $5,370 on healthcare, a decrease of 3.56% between 2020 and 2022. 9.26% of the overall cost of healthcare is made up of out-of-pocket payments.

In France, coronary artery disease is the main cause of death, accounting for 17% of all fatalities. Men in France have a CAD incidence rate of 3 per 1000 person-years, compared to women who have a CAD incidence rate of 2. It is also notable how common CAD is in France. Living with CAD are 3.5 million persons in France. More than 20% of adults over the age of 65 have the condition, which has a higher prevalence among older people. Coronary stents are medical devices that help treat coronary artery disease by widening the heart's constrictive or obstructed arteries and restoring normal blood flow. Comparing coronary stent use to more conventional therapies like medicine or bypass surgery, there are several benefits to be noted. By enlarging restricted or obstructed arteries, stents can increase blood flow to the heart muscle. This can lessen the likelihood of having a heart attack and relieve symptoms like chest pain. A smaller incision is needed for stenting than for bypass surgery since it is less intrusive. Patients may experience a quicker recovery and less pain as a result.

France Coronary Stents Market Analysis

Market Dynamics

Market Growth Drivers

In France, stent installation is one of many minimally invasive procedures that are becoming more popular. The use of stents is becoming more popular because patients frequently prefer them to more invasive procedures like bypass surgery. The management of cardiovascular disease is a top concern for the French government, which supports programmes aimed at both preventing and treating the condition. Increased funding for cardiac operations, such as the implantation of stents, may result from this support. Given that older people are more likely to acquire coronary artery disease, the ageing population in France is also anticipated to contribute to an increase in demand for coronary stents.

Market Restraints

In France, blood clots, haemorrhage, and infection are risks associated with stent implantation procedures. Some people could be discouraged from having the surgery done because of these hazards. While some insurers do offer some coverage for stent installation operations, getting paid for these treatments can be difficult. Because of this, certain patients might not be eligible for stent insertion. While bypass surgery and medication are two more therapeutic choices for coronary artery disease, stents are a frequently used option. For their market share to remain stable, manufacturers must contend with these alternative therapies.

Competitive Landscape

Key Players

Stentys (FR)
Delacroix-Chevalier (FR)
Marquat (FR)
Biotronik
Boston Scientific
B. Braun
Abbott Laboratories
GE Healthcare
Medtronic
Philipps Healthcare

Healthcare Policies and Regulatory Landscape

The healthcare system in France is well-established and subject to extensive government regulation. The French government is in charge of making certain that all citizens have access to and can afford healthcare products and services that adhere to high standards of safety and efficacy. The National Agency for Medicines and Health Products Safety (ANSM), a French regulatory body, has imposed tight guidelines for makers of coronary stents. All medical equipment sold in France, including coronary stents, must be evaluated and approved by ANSM. Before their products may be licenced for use in France, manufacturers must submit comprehensive information about the safety and efficacy of their products and go through extensive testing and evaluation.

1. Executive Summary
1.1 Device Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Regulatory Landscape for Medical Device
1.6 Health Insurance Coverage in Country
1.7 Type of Medical Device
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Market Size (With Excel and Methodology)
2.2 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Coronary Stents Market Segmentation

By Type (Revenue, USD Billion):

The three main categories of coronary stents are bare-metal, drug-eluting, and bioabsorbable, depending on their nature. The segment for bioabsorbable stents is anticipated to increase at the fastest rate over the forecast period. The benefits that are encouraging the use of bioabsorbable stents include a decrease in problems including thrombosis and inflammation, the cFranceity to restore normal vasomotion, and an improvement in aberrant endothelial function. However, in the upcoming years, the expansion of this market segment is anticipated to be constrained by the high cost of bioabsorbable stents.

Bare-metal Stents
Drug-eluting Stents
Bioabsorbable Stents

By Mode of Delivery (Revenue, USD Billion):

The market is divided into self-expanding and balloon-expandable stents according to delivery method. Because of the high use of these stents, rising research initiatives to advance the technology, and rising regulatory approvals for balloon-expandable stents, the balloon expandable stents segment is anticipated to increase at the greatest CAGR over the projection period.

Balloon-expandable Stents
Self-expanding Stents

By Materials (Revenue, USD Billion):

The coronary stent market is divided into metallic (cobalt chromium, platinum chromium, nickel-titanium, and stainless steel) and other stents according to the material. The market for other stents is anticipated to experience the largest CAGR growth during the projection period. The rapid expansion of this market can be ascribed to the increased use of polymers and copolymers in the production of bioabsorbable stents.

Metallic Stents
Cobalt-Chromium
Platinum Chromium
Nickel Titanium
Stainless Steel
Other Stents

By End User (Revenue, USD Billion):

The coronary stent market is divided into hospitals, cardiac centres, and ambulatory surgical centres based on the end user. According to predictions, the hospital sector will control the market in 2016. This is primarily caused by hospitals using a lot of coronary stents.

Hospitals
Cardiac Centers
Ambulatory Surgical Centers

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

Analyzing historical proprietary data collected from multiple projects.
Regularly updating our existing data sets with new findings and trends.
Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

Searching through academic conferences, published research, citations, and social media platforms
Collecting and compiling diverse data to build a comprehensive and detailed database
Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
Continuously refreshing our database to ensure that the information remains current and reliable.
Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

Merging historical data from secondary research with real-time data from primary research.
Conducting thorough data validation and cleansing to remove inconsistencies and errors.
Organizing data into a structured format that is easily accessible and usable for various applications.
Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.